Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Survivorship. J Surg Oncol 2015 Apr;111(5):648-55

Date

01/06/2015

Pubmed ID

25557722

DOI

10.1002/jso.23844

Scopus ID

2-s2.0-84925425829   6 Citations

Abstract

Significant therapeutic advances for soft tissue sarcomas allow increasing numbers of patients--adult and pediatric--to achieve long term survival. However, the harsh cytotoxic therapies are responsible for adverse physical and psychosocial effects that require long-term follow-up care, specific to survivorship issues. In the adult and pediatric patient population, guidelines for care developed by experts in comprehensive survivorship clinics are evolving to assist the practitioner while on-line supports bring information directly to the survivors.

Author List

Harrison DJ, Schwartz C

Author

Cindy L. Schwartz MD, MPH Chief, Professor in the Pediatrics department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Adult
Child
Humans
Sarcoma
Survivors
jenkins-FCD Prod-461 7d7c6113fc1a2757d2947d29fae5861c878125ab